1. Home
  2. MSBI vs ARMP Comparison

MSBI vs ARMP Comparison

Compare MSBI & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Midland States Bancorp Inc.

MSBI

Midland States Bancorp Inc.

N/A

Current Price

$21.96

Market Cap

456.2M

Sector

Finance

ML Signal

N/A

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$8.09

Market Cap

383.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MSBI
ARMP
Founded
1881
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
456.2M
383.7M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
MSBI
ARMP
Price
$21.96
$8.09
Analyst Decision
Hold
Strong Buy
Analyst Count
3
2
Target Price
$22.83
$15.00
AVG Volume (30 Days)
99.1K
40.8K
Earning Date
04-29-2026
05-13-2026
Dividend Yield
6.09%
N/A
EPS Growth
N/A
53.40
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.41
N/A
Revenue Next Year
$2.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.24
$0.90
52 Week High
$24.57
$13.75

Technical Indicators

Market Signals
Indicator
MSBI
ARMP
Relative Strength Index (RSI) 53.12 42.76
Support Level $20.47 $5.14
Resistance Level $22.29 $12.11
Average True Range (ATR) 0.57 0.90
MACD 0.10 -0.44
Stochastic Oscillator 81.64 24.72

Price Performance

Historical Comparison
MSBI
ARMP

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: